Investigating the Effect of Erithropoietin on Neurologic Outcome in Brain Ischemic Patients
Not Applicable
- Conditions
- Brain Ischemic Patients.Vascular syndromes of brain in cerebrovascular diseases
- Registration Number
- IRCT2013052713486N1
- Lead Sponsor
- Kermanshah Medical Science University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The inclusion criterion is brain ischemic Patients between 18 to 75 years of age range who have been hospitilized in ICU wards and have GCS,9. The exclusion criterion for the present study is those outside the age range mentioned-from 18 to 75- Non-ischemic patients , poly-sythemic patients, and those having another brain-related diseases -GCS<9, malignant cancer, disordered liver function, and pregnant women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glasgow Coma Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: Glasgow Coma Scale.;Glasgow Outcome Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: Glasgow Outcome Scale.;National Institutes of Health Stroke Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: National Institutes of Health Stroke Scale.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: The last day of hospitalization. Method of measurement: Numeration of hospitalizing days.